Immunotherapy Target Suppresses Pain to Mask Cancer – Duke Today
Duke Today |
Immunotherapy Target Suppresses Pain to Mask Cancer
Duke Today The researchers showed that a molecule called PD-L1, which is blocked by the popular immunotherapy drug nivolumab, acts not only on immune cells but also on the nerve cells that signal pain. That insight could lead to a simple test that measures subtle … |
